HS-IT101 Injection in the Treatment of Advanced Solid Tumors

Conditions: Solid Tumor Interventions: Drug: HS-IT101 Injection Sponsors: Qingdao Sino-Cell Biomedicine Co., Ltd.; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; The First Hospital of Jilin University; West China Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials